本页面由Tiger Trade Technology Pte. Ltd.提供服务

Denali Therapeutics Inc.

18.39
-0.5600-2.96%
成交量:104.56万
成交额:1,924.79万
市值:29.40亿
市盈率:-6.49
高:18.82
开:18.82
低:18.15
收:18.95
52周最高:27.30
52周最低:13.75
股本:1.60亿
流通股本:1.51亿
量比:0.57
换手率:0.69%
股息:- -
股息率:- -
每股收益(TTM):-2.8353
每股收益(LYR):-2.9700
净资产收益率:-54.93%
总资产收益率:-29.15%
市净率:3.52
市盈率(LYR):-6.19

数据加载中...

2020/02/28

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/02/27

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/27

重要事件披露

Current report, items 2.02 and 9.01
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/11

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/10

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/01/29

重要事件披露

Current report, items 1.01, 8.01, and 9.01
2020/01/27

重要事件披露

Current report, items 2.02, 8.01, and 9.01
2020/01/16

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/14

重要事件披露

Current report, item 8.01
2019/11/06

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/11/06

重要事件披露

Current report, items 2.02 and 9.01
2019/10/25

持股变动声明

Statement of changes in beneficial ownership of securities
2019/09/11

SEC问询函

[Cover]Correspondence
2019/09/11

持股变动声明

Statement of changes in beneficial ownership of securities
2019/09/05

持股变动声明

Statement of changes in beneficial ownership of securities